Nebulized Procaterol Versus Nebule Salbutamol for the Treatment of Moderate Acute Asthma

The Efficacy of Nebulized Procaterol Versus Nebulized Salbutamol for the Treatment of Moderate Acute Asthma: a Randomized, Double-blind, Parallel Group Study

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00990847

Enrollment

140

Registered

2009-10-07

Start date

2007-06-30

Completion date

2008-08-31

Last updated

2009-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moderate Acute Asthma

Brief summary

The purpose of this study is to compare the efficacy and safety of nebule procaterol with nebule salbutamol in the treatment of moderate acute asthma.

Interventions

DRUGProcaterol, Salbultamol

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

15 Years to 60 Years

Healthy volunteers

Inclusion criteria

1. Patients with moderate acute asthma according to Global Initiative for Asthma (GINA) 1998 (Appendix 1). Patients with moderate acute asthma according to Modified Global Initiative for Asthma (GINA) 1998 (Patients with asthma score 5 - 11; PEFR ≤ 80% predicted) 2. Patients of both gender aged 15 to 60 years 3. Patients still have the ability to undergo examinations and give written informed consent

Exclusion criteria

1. Pregnant and lactating women 2. Smokers 3. Patients with heart disease, hyperthyroidism, diabetes mellitus, COPD or other chronic diseases 4. Patients with signs of severe infections

Design outcomes

Primary

Measure	Time frame
Difference 5% from baseline in peak expiratory flow rate (PEFR)	3 times every 20 minutes (at 0, 20 and 40 minutes)

Secondary

Measure	Time frame
Difference 5% from baseline in asthma score	3 times every 20 minutes (at 0, 20 and 40 minutes)

Countries

Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026